| Patent | Date |
|---|
Process For The Preparation Of A Pyrimidino-diazepine Derivative
App 20220289755 - SKEAD; Benjamin ; et al. | 2022-09-15 |
Crystalline Forms Of Pyrimidino Diazepine Derivative
App 20220281880 - SKEAD; Benjamin ; et al. | 2022-09-08 |
Process for preparing purine derivatives
Grant 10,927,113 - Skead , et al. February 23, 2 | 2021-02-23 |
Dosing Regimen
App 20200129509 - CHIAO; Judy H. | 2020-04-30 |
Process For Preparing Purine Derivatives
App 20190389863 - SKEAD; Ben ; et al. | 2019-12-26 |
Dosage Regimen For Sapacitabine And Decitabine In Combination For Treating Acute Myeloid Leukemia
App 20190314396 - CHIAO; Judy H. | 2019-10-17 |
Dosing Regimen
App 20190298718 - CHIAO; Judy H. | 2019-10-03 |
Dosage regimen for sapacitabine and decitabine in combination for treating acute myeloid leukemia
Grant 10,226,478 - Chiao | 2019-03-12 |
Dosage regimen for sapacitabine and seliciclib
Grant 9,872,874 - Chiao , et al. January 23, 2 | 2018-01-23 |
Dosing regimens for treatment of proliferative disorders comprising administration of sapacitabine
Grant 9,675,631 - Chiao June 13, 2 | 2017-06-13 |
Crystalline forms of a purine derivative
Grant 9,573,951 - Skead , et al. February 21, 2 | 2017-02-21 |
Pyrimidine derivatives as protein kinase inhibitors
Grant 9,493,471 - Hollick , et al. November 15, 2 | 2016-11-15 |
Pyrimidine Derivatives As Protein Kinase Inhibitors
App 20150344486 - HOLLICK; Jonathan James ; et al. | 2015-12-03 |
Treatment Of Proliferative Diseases With Pyrimidodiazepinones
App 20150320762 - DAVIS; Susan ; et al. | 2015-11-12 |
Combination of a purine-based CDK inhibitor with a tyrosine kinase inhibitor and use thereof in the treatment of proliferative disorders
Grant 9,173,938 - Green , et al. November 3, 2 | 2015-11-03 |
Pyrimidine derivatives as protein kinase inhibitors
Grant 9,133,199 - Hollick , et al. September 15, 2 | 2015-09-15 |
Dosage Regimen For Sapacitabine And Seliciclib
App 20150164933 - Chiao; Judy H. ; et al. | 2015-06-18 |
Crystalline Forms Of A Purine Derivative
App 20150148354 - SKEAD; Benjamin Mark ; et al. | 2015-05-28 |
Combinations of sapacitabine or CNDAC with DNA methyltransferase inhibitors such as decitabine and procaine
Grant 8,975,239 - Green , et al. March 10, 2 | 2015-03-10 |
Crystalline forms of a purine derivative
Grant 8,889,861 - Skead , et al. November 18, 2 | 2014-11-18 |
Preparation of intermediates useful in the synthesis of 2'-cyano-2'-deoxy-N4-palmi-toyl-1-.beta.-D-arabinofuranosylcytosine
Grant 8,884,001 - Wood , et al. November 11, 2 | 2014-11-11 |
Purine derivatives
Grant 8,846,696 - Fischer , et al. September 30, 2 | 2014-09-30 |
Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseases
Grant 8,809,350 - Benigni , et al. August 19, 2 | 2014-08-19 |
Dosing Regimens For Treatment Of Proliferative Disorders Comprising Administration Of Sapacitabine
App 20140142058 - CHIAO; Judy H. | 2014-05-22 |
Combinations Of Sapacitabine Or Cndac With Dna Methyltransferase Inhibitors Such As Decitabine And Procaine
App 20140100187 - GREEN; Simon Richard ; et al. | 2014-04-10 |
Pyrimidine Derivatives As Protein Kinase Inhibitors
App 20140066436 - HOLLICK; Jonathan James ; et al. | 2014-03-06 |
Trisubstituted purine derivatives
Grant 8,592,581 - Sheldrake , et al. November 26, 2 | 2013-11-26 |
Pyrimidine derivatives as protein kinase inhibitors
Grant 8,563,542 - Hollick , et al. October 22, 2 | 2013-10-22 |
Dosing regimens for treatment of proliferative disorders comprising administration of sapacitabine
Grant 8,536,188 - Chiao September 17, 2 | 2013-09-17 |
Combinations of sapacitabine or CNDAC with DNA methyltransferase inhibitors such as decitabine and procaine
Grant 8,530,445 - Green , et al. September 10, 2 | 2013-09-10 |
Combination Comprising Cndac (2'-cyano-2'-deoxy-n4-palmitoyl-1-beta-d-arabinofuranosyl-cytosine) And A Cytotoxic Agent
App 20130196938 - GREEN; Simon Richard ; et al. | 2013-08-01 |
Crystalline pyrimidine nucleoside derivative suspensions in capsules
Grant 8,497,291 - Westwood , et al. July 30, 2 | 2013-07-30 |
Pyrimidin-4-yl-3, 4-dihydro-2H-pyrrolo [1,2A] pyrazin-1-one compounds
Grant 8,404,692 - Jones , et al. March 26, 2 | 2013-03-26 |
Crystalline Forms Of A Purine Derivative
App 20130072504 - Skead; Benjamin Mark ; et al. | 2013-03-21 |
Combination comprising CNDAC (2'-cyano-2'-deoxy-N4-palmitoyl-1-beta-D-arabinofuranosyl-cytosine) and a cytotoxic agent
Grant 8,349,792 - Green , et al. January 8, 2 | 2013-01-08 |
Method For Selecting A Cancer Therapy
App 20130005747 - GREEN; Simon Richard ; et al. | 2013-01-03 |
Purine And Pyrimidine Cdk Inhibitors And Their Use For The Treatment Of Autoimmune Diseases
App 20120309723 - BENIGNI; Ariela ; et al. | 2012-12-06 |
Methods of treatment using sapacitabine
Grant 8,124,593 - Gianella-Borradori , et al. February 28, 2 | 2012-02-28 |
Preparation Of Intermediates Useful In The Synthesis Of 2'-cyano-2'-deoxy-n4-palmi-toyl-1-beta-d-arabinofuranosylcytosine
App 20110224421 - Wood; Gavin ; et al. | 2011-09-15 |
Combinations Of Sapacitabine Or Cndac With Dna Methyltransferase Inhibitors Such As Decitabine And Procaine
App 20110207692 - Green; Simon Richard ; et al. | 2011-08-25 |
Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy
Grant 7,902,361 - Wang , et al. March 8, 2 | 2011-03-08 |
Pyrimidine compounds
Grant 7,897,605 - Wang , et al. March 1, 2 | 2011-03-01 |
Pyrimidine Derivatives As Protein Kinase Inhibitors
App 20110046093 - Hollick; Jonathan James ; et al. | 2011-02-24 |
Combination of a CDK inhibitor and CS-682 or a metabolite thereof
Grant 7,772,207 - Green , et al. August 10, 2 | 2010-08-10 |
Combination Of A Purine-based Cdk Inhibitor With A Tyrosine Kinase Inhibitor And Use Thereof In The Treatment Of Proliferative Disorders
App 20100143350 - GREEN; Simon ; et al. | 2010-06-10 |
Dosing Regimens For Treatment Of Proliferative Disorders Comprising Administration Of Sapacitabine
App 20100125084 - Chiao; Judy | 2010-05-20 |
Compounds
App 20100093769 - SHELDRAKE; Peter William ; et al. | 2010-04-15 |
Combination Comprising Cndac (2'-cyano-2'-deoxy-n4-palmitoyl-1-beta-d-arabinofuranosyl-cytosine) And A Cytotoxic Agent
App 20100069291 - Green; Simon ; et al. | 2010-03-18 |
Pyrimidin-4-yl-3, 4-Dihydro-2H-Pyrrolo[1,2A] Pyrazin-1-one Compounds
App 20100035870 - Jones; Stuart ; et al. | 2010-02-11 |
New Purine Derivatives
App 20090325983 - FISCHER; Peter Martin ; et al. | 2009-12-31 |
4-(1H-Indol-3-yl)-Pyrimidin-2-Ylamine Derivatives and Their Use in Therapy
App 20090318446 - Fischer; Peter Martin ; et al. | 2009-12-24 |
Combination Of Roscovitine And A Hdca Inhibitor To Treat Proliferative Diseases
App 20090306098 - Green; Simon ; et al. | 2009-12-10 |
Antiproliferative Combination Comprising Cyc-682 And A Cytotoxic Agent
App 20090274773 - Green; Simon ; et al. | 2009-11-05 |
2,6,9-substituted purine derivatives and their use in the treatment of proliferative disorders
Grant 7,612,079 - Fischer , et al. November 3, 2 | 2009-11-03 |
Purine Derivatives
App 20090270427 - FISHER; Peter Martin ; et al. | 2009-10-29 |
Purine derivatives
Grant 7,582,642 - Fischer , et al. September 1, 2 | 2009-09-01 |
4-Heteroaryl Pyrimidine Derivatives and use thereof as Protein Kinase Inhibitors
App 20090215805 - Wood; Gavin ; et al. | 2009-08-27 |
Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases
Grant 7,576,091 - McInnes , et al. August 18, 2 | 2009-08-18 |
Purine derivatives
Grant 7,544,689 - Fischer , et al. June 9, 2 | 2009-06-09 |
Methods of Treatment Using Sapacitabine
App 20090118315 - Gianella-Borradori; Athos ; et al. | 2009-05-07 |
Crystalline Pyrimidine Nucleoside Derivative Suspensions In Capsules
App 20090074856 - Westwood; Robert ; et al. | 2009-03-19 |
Compounds
App 20080318954 - Duncan; Kenneth ; et al. | 2008-12-25 |
Pyrimidine compounds
App 20080287439 - Wang; Shudong ; et al. | 2008-11-20 |
p21 peptides
Grant 7,449,544 - Zheleva , et al. November 11, 2 | 2008-11-11 |
Methods and Means For Inhibition of CDK4 Activity
App 20080249025 - Ball; Kathryn Lindsay ; et al. | 2008-10-09 |
N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds
Grant 7,427,627 - Wang , et al. September 23, 2 | 2008-09-23 |
N-(4-(4-methylthiazol-5-yl)pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds
Grant 7,388,015 - Wang , et al. June 17, 2 | 2008-06-17 |
Method for Identifying Inhibitors Using a Homology Model of Polo-Like Kinase 1
App 20080132484 - McInnes; Campbell ; et al. | 2008-06-05 |
Purine and Pyrimidine Cdk Inhitbitors and Their use for The Treatment of Autoimmune Diseases
App 20080125404 - Benigni; Ariela ; et al. | 2008-05-29 |
Medicament
Grant 7,312,356 - Fischer , et al. December 25, 2 | 2007-12-25 |
Cell cycle progressional proteins
App 20070269433 - Deak; Peter ; et al. | 2007-11-22 |
Inhibitors of cyclin dependent kinases as anti-cancer agent
Grant 7,262,202 - Fischer , et al. August 28, 2 | 2007-08-28 |
Inhibitors of cyclin dependent kinases as anti-cancer agent
App 20070185134 - Fischer; Peter Martin ; et al. | 2007-08-09 |
Modified peptide derivatives and methods of use thereof
Grant 7,223,795 - Walkinshaw , et al. May 29, 2 | 2007-05-29 |
Pyrimidin-4-YL-3, 4-thione compounds and their use in therapy
App 20070021452 - Wang; Shudong ; et al. | 2007-01-25 |
2-Aminophenyl-4-phenylpyrimidines as kinase inhibitors
App 20070021419 - Wang; Shudong ; et al. | 2007-01-25 |
Compositions and methods for monitoring the modification state of a pair of polypeptides
Grant 7,166,475 - Colyer , et al. January 23, 2 | 2007-01-23 |
P21 derived peptides and uses thereof
App 20060293245 - Zheleva; Daniella I. ; et al. | 2006-12-28 |
Transport vectors
Grant 7,153,931 - Fischer , et al. December 26, 2 | 2006-12-26 |
Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases
App 20060264628 - McInnes; Campbell ; et al. | 2006-11-23 |
Pyridinylamino-pyrimidine derivatives as protein kinase inhibitors
App 20060241297 - Wang; Shudong ; et al. | 2006-10-26 |
Markers for cyclin dependent kinase inhibitors
App 20060204975 - Green; Simon R. ; et al. | 2006-09-14 |
Compositions and methods for screening for modulators of enzymatic activity
Grant 7,105,307 - Colyer , et al. September 12, 2 | 2006-09-12 |
N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds
App 20060199830 - Wang; Shudong ; et al. | 2006-09-07 |
Transport vectors
Grant 7,101,967 - Fischer , et al. September 5, 2 | 2006-09-05 |
Markers for roscovitine
App 20060188898 - Green; Simon R. ; et al. | 2006-08-24 |
Triterpenoid derivatives
App 20060160890 - Hajduch; Marian ; et al. | 2006-07-20 |
Combination comprising a CDK inhibitor and a topoisomerase 1 inhibitor for the treatment of cancer and other proliferative diseases
App 20060148828 - Gianella-Borradori; Athos ; et al. | 2006-07-06 |
Compositions and methods for monitoring enzyme activity
App 20060148017 - Colyer; John ; et al. | 2006-07-06 |
Compositions and methods for monitoring the modification of modification dependent binding partner polypeptides
Grant 7,060,506 - Craig June 13, 2 | 2006-06-13 |
Carrier based drug delivery system
Grant 6,992,169 - Fischer , et al. January 31, 2 | 2006-01-31 |
Combination comprising docetaxel and a CDK inhibitor
App 20050277656 - Gianella-Borradori, Athos | 2005-12-15 |
Combination comprising a CDK inhibitor and cisplatin
App 20050276866 - Gianella-Borradori, Athos | 2005-12-15 |
Methods and compositions using protein binding partners
Grant 6,972,198 - Craig , et al. December 6, 2 | 2005-12-06 |
Methods and compositions using coiled binding partners
Grant 6,972,182 - Colyer , et al. December 6, 2 | 2005-12-06 |
Pharmaceutical composition comprising a CDK inhibitor and gemcitabine
App 20050267066 - Gianella-Borradori, Athos | 2005-12-01 |
Combination of a CDK inhibitor and mitoxantrone
App 20050261260 - Gianella-Borradori, Athos | 2005-11-24 |
Methods and means for inhibition of Cdk4 activity
Grant 6,962,792 - Ball , et al. November 8, 2 | 2005-11-08 |
Cell cycle progression proteins
App 20050227243 - Deak, Peter ; et al. | 2005-10-13 |
Combination comprising a CDK inhibitor and doxorubicin
App 20050222054 - Sleigh, Roger Neil ; et al. | 2005-10-06 |
Bisarylsulfonamide compounds and their use in cancer therapy
App 20050215548 - Wang, Shudong ; et al. | 2005-09-29 |
Antitumour vector constructs and methods
Grant 6,943,026 - Balmain , et al. September 13, 2 | 2005-09-13 |
Combination of a cdk inhibitor and 5-fu for the tratment of cancer
App 20050164976 - Green, Simon Richard ; et al. | 2005-07-28 |
p21 peptides
App 20050153894 - Zheleva, Daniella I. ; et al. | 2005-07-14 |
Methods of treatment of chronic lymphocytic leukemia using roscovitine
App 20050153991 - Gianella-Borradori, Athos ; et al. | 2005-07-14 |
Assay for measuring enzyme activity in vivo
Grant 6,852,906 - Craig , et al. February 8, 2 | 2005-02-08 |
Methods and compositions using coiled binding partners
Grant 6,828,106 - Colyer , et al. December 7, 2 | 2004-12-07 |
Methods of monitoring enzyme activity
Grant 6,808,874 - Griffiths October 26, 2 | 2004-10-26 |
p21 peptides
App 20040176301 - Zheleva, Daniella I. ; et al. | 2004-09-09 |
Anti-cancer compounds
Grant 6,699,854 - Wang , et al. March 2, 2 | 2004-03-02 |
Cyclin dependent kinase binding compounds
App 20040029791 - Fahraeus, Robin ; et al. | 2004-02-12 |
Compositions and methods for monitoring the phosphorylation of natural binding partners
Grant 6,670,144 - Craig , et al. December 30, 2 | 2003-12-30 |
Treatment of autoimmune disorders
App 20030229105 - Kashanchi, Fatah | 2003-12-11 |
Compositions and methods for monitoring the phosphorylation of natural binding partners
App 20030203407 - Craig, Roger K. ; et al. | 2003-10-30 |
PCNA binding substance
Grant 6,613,878 - Cox , et al. September 2, 2 | 2003-09-02 |
Cell cycle progression proteins
App 20030152945 - Deak, Peter ; et al. | 2003-08-14 |
Anti-cancer compounds
App 20030149057 - Wang, Shudong ; et al. | 2003-08-07 |
Chemical modification
App 20030104504 - Colyer, John ; et al. | 2003-06-05 |
Anti-cancer compounds
Grant 6,531,479 - Wang , et al. March 11, 2 | 2003-03-11 |
Carrier based drug delivery system
Grant 6,472,507 - Fischer , et al. October 29, 2 | 2002-10-29 |
Compositions and methods for monitoring the modification of natural binding partners
Grant 6,465,199 - Craig , et al. October 15, 2 | 2002-10-15 |
Transport vectors
App 20020098236 - Fischer, Peter Martin ; et al. | 2002-07-25 |
| 